American Health Network of Indiana, LLC
Avon, Indiana, United States
Medical office in Avon, Indiana
8607 E US Hwy 36, Avon, IN 46123
About American Health Network of Indiana, LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
8
AstraZeneca
6
Hoffmann-La Roche
5
Bristol-Myers Squibb
4
Boehringer Ingelheim
3
Eli Lilly and Company
3
Intarcia Therapeutics
3
Janssen Vaccines & Prevention B.V.
3
Apple Inc.
2
Boston Scientific Corporation
2
Fairbanks Institute
2
Clinical Trials at American Health Network of Indiana, LLC
During the past decade, American Health Network of Indiana, LLC conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 20 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
2002-05-01
2003-08-01
Completed
734
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
2002-03-01
2003-06-01
Completed
336
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
2002-02-01
2003-08-01
Completed
377
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
2004-09-01
2009-10-01
Completed
1,783
A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
2005-11-01
2009-10-01
Completed
74
Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma
2006-04-01
2007-07-01
Completed
210
Study of XL999 in Patients With Acute Myeloid Leukemia (AML)
2006-05-01
2007-05-01
Terminated
14
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "American Health Network of Indiana, LLC" #1 sponsor was "Pfizer" with 8 trials, followed by "AstraZeneca" with 6 trials
sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored and "Boehringer Ingelheim"
with 4 trials sponsored. Other sponsors include 25 different institutions and
companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "American Health Network of Indiana, LLC"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "BioCrossroads" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Indiana University School of Medicine" with 2 trials as a collaborator and "Iqvia Pty Ltd" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at American Health Network of Indiana, LLC
According to Clinical.Site data, the most researched conditions in "American Health Network of Indiana, LLC" are
"Diabetes Mellitus, Type 2" (6 trials), "Alzheimer Disease" (4 trials), "Type 2 Diabetes" (4 trials), "Hyperlipidemia" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "American Health Network of Indiana, LLC" in a lesser frequency.
Clinical Trials Intervention Types at American Health Network of Indiana, LLC
Most popular intervention types in "American Health Network of Indiana, LLC" are "Drug" (44 trials), "Biological" (5 trials), "Other" (5 trials), "Device" (4 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "AC2993" (4 trials), "Ocrelizumab" (3 trials), "Bococizumab (PF-04950615; RN316)" (2 trials) and "Dapagliflozin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at American Health Network of Indiana, LLC
The vast majority of trials in "American Health Network of Indiana, LLC" are
55 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at American Health Network of Indiana, LLC
Currently, there are NaN active trials in "American Health Network of Indiana, LLC".
undefined are not yet recruiting,
6 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 34 completed trials in American Health Network of Indiana, LLC,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in American Health Network of Indiana, LLC, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 31 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 3 trials that are defined as “Not Applicable".